For cervical cancer, a French group reported that the combination of EGFR/HER3 dual antibody and chemoradiotherapy enhanced cancer cell death in cervical squamous cell carcinoma cells in vitro and a mouse model experiment [64]. This evidence concerns the gene EGFR and cancer.